Resources

Is extreme blood glucose control increasing or decreasing mortality rate in hospitalized patients?

HbA1c testing determines diabetes and prediabetes in patients who are not yet diagnosed

Does HbA1c variability predict retinopathy, nephropathy?

Is moderate exercising helping or hurting cardiovascular outcomes?

Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.

In the fasting state, hyperglycemia is directly related to: 1. Increased hepatic glucose production 2. Defective insulin stimulation of target tissue glucose disposal 3. Decreased adipocyte lipolysis 4. Loss of pancreatic α-cell functionality Did you get it right? Follow the link to find out!

Do you promote the use of metformin to help prevent cancer as well as to control blood sugars? Follow the link to share your opinion and see what your colleagues think!

Male, 26 years of age, type 2 diabetes, obesity, hyperlipidemia, hypertension. Strong family history of type 2 diabetes with complications. Has been a patient since diagnosed 2 years ago. Has met with dietitian. Hasn’t made dietary changes, increased activity, or taken meds prescribed to lower his glucose. A1C 9.2% and rising every 3 months. He would also miss many of his appointments. Stated, “Nothing is going to bother me. Maybe it did my family, but that was a different time and it’s not going to happen to me. I’m going to go on enjoying my life.”

In part 1 of this Exclusive Interview, Kimberly Ward explains the goal and use of the Accu-Chek Connect System.

In this week's Homerun Slides, the principles of the AACE/ACE comprehensive type 2 diabetes management algorithm.